With years of experience in recombinant antibody production, antibody engineering, bio-conjugation, and with the addition of the advanced “DrugLnk” organic synthesis platform, Creative Biolabs has estabilished a leading role in antibody-drug onjugates (ADCs) developments. Check more details about cleavable peptide linker: https://www.creative-biola...

Only people mentioned by catalinagarcia in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Catalina Garcia, click on at the bottom under it